Literature DB >> 22122591

Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus).

Michelle Nelson1, Rachel E Dean, Francisco J Salguero, Christopher Taylor, Peter C Pearce, Andrew J H Simpson, Mark S Lever.   

Abstract

Studies of inhalational melioidosis were undertaken in the common marmoset (Callithrix jacchus). Following exposure to an inhaled challenge with aerosolized Burkholderia pseudomallei, lethal infection was observed in marmosets challenged with doses below 10 cfu; a precise LD(50) determination was not possible. The model was further characterized using a target challenge dose of approximately 10(2) cfu. A separate pathogenesis time-course experiment was also conducted. All animals succumbed, between 27 and 78 h postchallenge. The challenge dose received and the time to the humane endpoint (1 °C below normal body temperature postfever) were correlated. The first indicator of disease was an increased core body temperature (T(c) ), at 22 h postchallenge. This coincided with bacteraemia and bacterial dissemination. Overt clinical signs were first observed 3-5 h later. A sharp decrease (typically within 3-6 h) in the T(c) was observed prior to humanely culling the animals in the lethality study. Pathology was noted in the lung, liver and spleen. Disease progression in the common marmoset appears to be consistent with human infection in terms of bacterial spread, pathology and physiology. The common marmoset can therefore be considered a suitable animal model for further studies of inhalational melioidosis.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Year:  2011        PMID: 22122591      PMCID: PMC3248079          DOI: 10.1111/j.1365-2613.2011.00791.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  38 in total

1.  Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins.

Authors:  S M Jones; J F Ellis; P Russell; K F Griffin; P C F Oyston
Journal:  J Med Microbiol       Date:  2002-12       Impact factor: 2.472

2.  Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.

Authors:  Philippe Bossi; Anders Tegnell; Agoritsa Baka; Frank Van Loock; Jan Hendriks; Albrecht Werner; Heinrich Maidhof; Georgios Gouvras
Journal:  Euro Surveill       Date:  2004-12-15

3.  A case of melioidosis in a macaque monkey.

Authors:  A Retnasabapathy; P G Joseph
Journal:  Vet Rec       Date:  1966-07-16       Impact factor: 2.695

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Pulmonary melioidosis associated with bronchiolitis obliterans organizing pneumonia.

Authors:  Andreas Jansen; Ralf M Hagen; Wolfgang Schmidt; Ralf Ignatius; Alejandra Perez-Canto; Martin Zeitz; Thomas Schneider
Journal:  J Infect       Date:  2005-01       Impact factor: 6.072

7.  A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei.

Authors:  Anna Easton; Ashraful Haque; Karen Chu; Roman Lukaszewski; Gregory J Bancroft
Journal:  J Infect Dis       Date:  2006-11-21       Impact factor: 5.226

8.  An outbreak of melioidosis in imported primates in Britain.

Authors:  D A Dance; C King; H Aucken; C D Knott; P G West; T L Pitt
Journal:  Vet Rec       Date:  1992-06-13       Impact factor: 2.695

9.  Melioidosis in imported non-human primates.

Authors:  A F Kaufmann; A D Alexander; M A Allen; R J Cronin; L A Dillingham; J D Douglas; T D Moore
Journal:  J Wildl Dis       Date:  1970-10       Impact factor: 1.535

Review 10.  Recent development in melioidosis.

Authors:  Amorn Leelarasamee
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

View more
  19 in total

1.  Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).

Authors:  John J Yeager; Paul Facemire; Paul A Dabisch; Camenzind G Robinson; David Nyakiti; Katie Beck; Reese Baker; M Louise M Pitt
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Novel multi-component vaccine approaches for Burkholderia pseudomallei.

Authors:  L Morici; A G Torres; R W Titball
Journal:  Clin Exp Immunol       Date:  2019-04-08       Impact factor: 4.330

3.  Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus).

Authors:  Michelle Nelson; Francisco J Salguero; Rachel E Dean; Sarah A Ngugi; Sophie J Smither; Timothy P Atkins; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2014-12-05       Impact factor: 1.925

4.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

5.  Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis.

Authors:  Carl Soffler; Angela M Bosco-Lauth; Tawfik A Aboellail; Angela J Marolf; Richard A Bowen
Journal:  Int J Exp Pathol       Date:  2014-02-27       Impact factor: 1.925

6.  Laboratory Safety: Handling Burkholderia pseudomallei Isolates without a Biosafety Cabinet.

Authors:  Ian Gassiep; Michelle J Bauer; Patrick N A Harris; Mark D Chatfield; Robert Norton
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 7.  An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing.

Authors:  Kristopher E Van Zandt; Apichai Tuanyok; Paul S Keim; Richard L Warren; H Carl Gelhaus
Journal:  Front Cell Infect Microbiol       Date:  2012-09-26       Impact factor: 5.293

8.  Clinical definitions of melioidosis.

Authors:  Allen C Cheng; Bart J Currie; David A B Dance; Simon G P Funnell; Direk Limmathurotsakul; Andrew J H Simpson; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2013-03       Impact factor: 2.345

9.  Genome Sequence of Burkholderia pseudomallei NCTC 13392.

Authors:  Jason W Sahl; Joshua K Stone; H Carl Gelhaus; Richard L Warren; Caroline J Cruttwell; Simon G Funnell; Paul Keim; Apichai Tuanyok
Journal:  Genome Announc       Date:  2013-05-23

10.  Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis.

Authors:  Richard J Thomas; C Davies; A Nunez; S Hibbs; L Eastaugh; S Harding; J Jordan; K Barnes; P Oyston; S Eley
Journal:  Front Cell Infect Microbiol       Date:  2012-07-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.